MEDICAL DICTIONARY
Sanfilippo syndrome: The most common disorder of mucopolysaccharide metabolism, a syndrome in which the onset of clinical abnormalities is between the ages of 2 and 6 with mild coarsening of the facial features (but normal clear corneas), mild stiffening of the joints, slowing of growth, and intellectual deterioration resulting in severe mental retardation.
On a biochemical level, Sanfilippo syndrome is characterized by the excess excretion of heparin sulfate alone in the urine and the accumulation of mucopolysaccharides in the central nervous system and other tissues. On the genetic level, there are 4 types of Sanfilippo syndrome (types A, B, C, and D), each due to deficiency of a different enzyme. All 4 types are inherited in an autosomal recessive manner and result in an identical clinical syndrome.
Also known as mucopolysaccharidosis Type III (MPS III).
|
DISCLAIMER:
Information on this site is provided for informational
purposes and is not meant to substitute for the advice
provided by your own physician or other medical professional.
You should not use the information contained herein
for diagnosing or treating a health problem or disease,
or prescribing any medication. You should read carefully
all product packaging. Not all Canadian drugs, Canada
prescription and Canadian prescription medicine is available
at discount Canadian on line pharmacies. If you have
or suspect that you have a medical problem, promptly
contact your health care provider. Information and statements
regarding diet supplements have not been evaluated by
Health Canada and are not intended to diagnose, treat,
cure, or prevent any disease. All trade and service
marks mentioned on this site are recognized as belonging
to their respective owners.
|
|
|
|
